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Epidemiologic Investigation of
Special Groups
Dr. David Parkinson (University of Pittsburgh
and International Steelworkers Union) opened the
discussion by reading a letter to a member of the
Steelworkers Union from his employer, stating
that the worker's employment had been termi-
nated because "extensive testing conducted by our
[the company's] physicians has indicated that you
[the worker] have unusual propensity to absorb
certain amounts of lead in your bloodstream and
tissues." The letter went on to state that the
worker had a greater response of blood lead than
other workers with similar exposures, and because
temporary removal from the work environment
was not a permanent solution to the problem, the
company was terminating his employment. Yet
two months previously the worker had been notified
that his exposure to lead had been to 21,224 ,ug/m3,
way above the current 8-hr standard of 100 ,ug/m3;
thus the worker's elevated blood lead had a clear
basis from excessive exposure, and was not simply
a propensity to absorb more. Dr. Parkinson there-
fore questioned the value of research on hyper-
susceptibility to environmental agents. He thought
that this meeting showed that epidemiology could
not help in providing clean conditions in the
workplace, and that perhaps the money spent on
epidemiological research would be better spent in
preventive measures to protect workers before
they are irreparably damaged.
Dr. Hunt replied that we are all concerned
about these issues, but made a distinction between
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the conduct of research and the implications aris-
ing from that research. Dr. Radford added that
the drop in the bucket that is represented in
dollars by the cost of all of the epidemiological
research in this country would not clean up ten
plants. He thought the issue of allocation of
financial resources was a lot broader than was
subsumed by the subject of this symposium. He
did not think that diverting money away from
research would really help; in fact it would bring
to a halt investigation of a great number of other
materials that may be affecting people, but about
which we know very little, in contrast to lead.
With regard to differences in susceptibility, from
the research standpoint he had a question for Dr.
Redmond, also germane to Dr. Murphy's com-
ments about binomialization. We must begin to
think of exposure populations as having a contin-
uum ofsusceptibility and his question was whether
a continuum ofsusceptibility modifies dose-response
curves at the low-dose end, and, ifso, in what way?
Dr. Redmond replied that a continuous distribu-
tion of susceptibilities could affect dose-response
relationships, but without any evidence it would
be difficult to predict in what way, precisely. If
various subsets of the population under study had
different dose-response curves characterized by
different slopes, indicating some subgroups are
more susceptible than others, the total dose response
could indeed be affected. Dr. Radford continued
by pointing out that in using epidemiologic data for
regulatory purposes, one is making the assumption
that the population studied is characteristic of the
population at large and, therefore, the data are
applicable to the general population. But if the
conditions of the study population are likely to
eliminate susceptible subsets, one might postulate
that any dose-response curve obtained in such a
study population could underestimate risk very
significantly at the low-dose end ofthe curve. A lot
of statements are made that linear extrapolations
141overestimate risk at low doses, but it could be just
the opposite. Dr. Redmond agreed that whether
or not the study population contains the suscepti-
bles, extrapolations to a general population may
very well lead to nonconservative estimates ofrisk
for susceptible subpopulations.
Dr. Charles Land (National Cancer Institute)
commented that if there are identifiable and sub-
stantial susceptible subpopulations that have a
much steeper dose-response curve and for whom
the effects might even saturate at low-dose levels,
one could get a superlinear dose-response curve.
The problem was that he did not know how to
analyze data with that kind of general hypothesis.
The dose-response relationship that you hypothe-
size provides the basis whereby data from people
exposed to high doses tell you something about
risks in people exposed to low doses. If you
assume that there is some sort of distribution of
extra-sensitive people, the study may have lost all
structure, and one is therefore reduced to study-
ing risk at low doses by studying people exposed
to low doses. He thought that there is no future in
such studies. Dr. Redmond agreed that in terms of
biological assay, attempting to define susceptibility
in a population survey violated all of the tenets of
good statistical design. She did not know a good
way to deal with the problem by statistical approach-
es, either.
Dr. Bernard Altshuler (New York University)
said that one would have to use scientific ingenu-
ity. Statistical analysis alone would not suffice. He
asked Dr. Redmond whether she thought it was
possible to identify susceptible subgroups. Is it
feasible for the epidemiologist to try to identify in
these studies subgroups which then can be exam-
ined, perhaps in other studies? The question is not
just to identify the subgroup, but to identify the
criteria for characterizing the special susceptibility
of a subgroup in advance. Dr. Redmond replied
that in many instances it was not, in that some of
the factors that one may have to consider as
predisposing factors are not clearly delineated.
Moreover, such isolation of special groups at risk
gets into methodological issues statistically that
have not been resolved at the present time. The
study may answer major questions about a heter-
ogeneous or mixed study population, but may be
limited with regard to sorting out population
subsets.
Dr. Hunt pointed out that the immature organ-
ism quite likely responds to environmental expo-
sure in a way different from the mature organism.
She had been quite surprised to find that it was
very difficult to retrieve from any of the Medline
literature search systems any designation ofjuve-
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nile, immature or adolescent individual, be it
animal or human. Her concern stemmed in part
from the problem ofexposure of 10 and 11-year old
children to pesticides in their workplace, namely,
hand-harvesting of short-term crops. Whether one
was concerned with immune responses or repro-
ductive effects, the body burden of a biologically
accumulating pollutant was not something to be
ignored at these ages. For example, between the
ages of 9 to 12, both the testes and the ovaries
doubled or tripled in weight; thus the developing
child could be at special risk from mutagens. She
thought it was time, both in laboratory animals
and in epidemiologic studies, to look more closely
at the early part of the lifespan.
Dr. Radford said in response to Dr. Land's
comments that he wanted to dispel the rather
hopeless implication about detecting low-dose effects.
One ofthe important results ofthis symposium has
been that epidemiologists who are going to be
dealing with these problems have become aware of
the great number of new tools that can help to
identify special populations at risk and begin to get
a quantitative assessment of how important they
are in determining low-dose effects. About ten
different promising susceptible subsets that need
to be looked at as special cases in terms of
reactions to environmental agents have already
been identified at this meeting alone. He thought
that studying low-dose effects is anything but
hopeless. That is the challenge that now faces
epidemiologic research: to begin to identify and
study these groups so that we can make much
better sense out of low-dose effects of a variety of
environmental agents. Dr. Land replied that he
was talking about the possibility there may be
unidentified subgroups, and the difficulties in this
case. If one can identify them in advance then you
have something.
Dr. Redmond said that her remarks were aimed
at putting the issues into perspective. As one who
is by training primarily a statistician, she felt that
she had to rely heavily on biologists as to what are
the biological mechanisms of disease and to know
what factors to build into studies and study
design. These concepts are important in elucidat-
ing whether or not there may be susceptible
subpopulations. Once data have been collected,
attempting to pull out groups that are somewhat
deviant from the total population raises important
questions about the appropriateness of such a
procedure. Dr. Altshuler agreed that the really
critical issue is whether the investigator can iden-
tify the special group in advance or not. Dr. Philip
Enterline (University of Pittsburgh) commented
that we should not lose sight ofsomething obvious:
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make them susceptible that epidemiologists can
identify very easily. An obvious example is ciga-
rette smokers exposed to asbestos, a subset of the
population which is susceptible to lung cancer.
Another characteristic is age, as Dr. Hunt men-
tioned. There could be characteristics ofresidence,
or people with hobbies may have unusual expo-
sures. He thought these are things that should be
addressed in more of our studies.
Dr. William A. McClellan (Gulf Science and
Technology Company) addressed a question to Dr.
Redmond or Dr. Murphy about the appropriate-
ness of extrapolating results from radiation effects
at low-dosage to the effects of chemicals at low-
dosage, which may differ for many reasons. Dr.
Redmond replied that she had not meant to imply
that results from one kind ofan exposure, whether
it be radiation, polycyclic hydrocarbons orwhatever,
could be applied to another situation where you
are dealing with different materials and different
responses. Decisions aboutappropriate dose-response
relationships have to be made based upon what is
known about the biology ofthe material, and what
seems reasonable from previous experience. One
should not take information from one totally dif-
ferent setting and apply it to another.
Dr. Murphy began by denying the major prem-
ise. As he had listened to the series of questions
asked, he thought that the assumption that the
way to look at an environmental factor and its
results is in terms of a dose-response curve at low
doses, was not at all obvious. For example, for a
man exposed to lead, could one not measure his
exposure and measure his blood lead level? This
approach does not get into problems of bionom-
ialization or any particular problems of low dos-
age. It may be that the level of lead in the
blood is only an intermediate stage between the
environmental hazard and what one is really inter-
ested in. Despite such objections, if one does not
use an empirical dose-response curve but instead
uses regression analysis, then he thought this
should be expressly addressed. This alternative is
possibly related to the comment about using sci-
ence: rather than using a black-box treatment of a
relatively crude outcome, to use a relatively refined
regression variable in analyzing results. He also
commented that if one is talking about taking
money away from the study of genetics, why don't
we go whole hog and put most funding into the
study of moral philosophy?
Dr. J. Wanless Southwick (Utah State Depart-
ment of Health) asked: If we recognize that
environmental quality is a continuum of "dosage
levels" over time and space, rather than simply a
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binomial bad or good quality, and if we construe a
standard to be something ofa dividingline between
acceptable and unacceptable exposures, and if we
further assume that somewhere in the general
population there are individuals who make up a
subset of susceptibles that may be difficult or even
impossible to identify, how then do we set stan-
dards? Specifically, how do we re-evaluate stan-
dards that have already been set based on limited
data? Do we set more stringent standards for
well-known and unpopular pollutants? Is there an
inevitable vested interest struggle between the
producer of the pollutant, who wants to minimize
costs, and the regulator, who wants to maintain
the public image of an unyielding champion of
public health? In short, his question was: Do
epidemiologists and their findings actually have
much to do with the standard-setting process?
Dr. Hunt replied that for those who have had
front-line experience of having to deal with what
was eitherinadequate or poor qualityepidemiologic
studies in the standard setting exercise, the pro-
cess was difficult. She had watched with sympathy
her colleagues struggle with this problem, know-
ing that there would be criticism of a study, not
necessarily because of the quality of the work the
epidemiologist did, but because the reality of a
study population was not as good as if one studied
rats in the laboratory instead. She commented on
the case of the Alsea study, in which a decision
was made not to set a standard but to issue a
regulatory decision concerning the exposure of
human populations to 2,4,5-T and its contaminant,
dioxin. The experience is interesting to recount,
because the media event the Alsea study became
made it quite reasonable to everybody watching
the scene, whether scientists or the general public,
that the subsequent decision made by the Envi-
ronmental Protection Agency to suspend that
herbicide for a large number of uses was made on
the basis of those Alsea findings. In fact, in the
decision process that went on, the Alsea study was
simply a trigger to a re-evaluation of the animal
toxicology for 2,4,5-T and dioxin. It was decided
that the appropriate, prudent public health prac-
tice was to take action on the basis of the animal
toxicology, when there was suspicion of human
effect. The decision was not based on the inade-
quate epidemiology. EPA looks upon the 2,4,5-T
dioxin issue as a serious concern. The scientific
foundations that go into decision-making involve
not just one component, but many lines of evi-
dence that are interactive. Those who have the
final decision do take account of many sources of
scientific evidence, no matter what some scientists
think and the media present to the public.
143Dr. Robert Chapman (EPA, Research Triangle
Park, North Carolina) said that he had not been
involved directly in the standard-setting process,
but in the first phases of the standard-setting
process, at least for the ozone standard with which
he had worked, epidemiology figured quite promi-
nently. There had been a very reassuring kind of
interaction between the regulators and the epide-
miologists at EPA in North Carolina. As the
author of the epidemiology chapter in the criteria
document for ozone and photochemical oxidant, he
had been consulted frequently by people in the
Office of Air Quality Planning and Standards as to
the reasonableness of things they were writing.
They consulted him more than he sometimes
wanted, but he had no hesitation in saying they
were extremely conscientious in wanting not to
wander too far afield of what was reasonable in
terms of available data, especially epidemiologic
data, and the evidence of significant biomedical
effects. The OAQPS finally defined a range of
about 0.08 to 0.12 ppm hourly average, within
which the photochemical oxidant standard might
be reasonably set, and within which it was difficult
to give priority of one value over another from the
available biomedical evidence. In his view in this
case, at least, the standard-setting process definitely
did take account of epidemiologic evidence.
Dr. Parkinson stated that his experience had
been a totally different one. He had been chief of
the Occupational Health Branch in California for a
couple of years, and was involved in standard
setting there. Because of limited resources, one
had to set priorities for the sort of substances that
should be aggressively regulated. He never found
that he could use epidemiologic results to set
priorities. The priorities were, unfortunately, set
by many factors. One has to recognize that what
happens in that sort ofpressure cooker, whether it
is a state health department or the federal Occupa-
tional Safety and Health Administration, is that
priorities are influenced by pressures which are
not based upon science or upon epidemiology. The
OSHA regulations demonstrate this fact. In the 23
standards set since the initial promulgation of the
Act, he could not think of any of the 23 where a
conscious decision had been made that those 23
were the important substances for which stan-
dards should be set. Secondly, in none of the 23
could he think of an instance where epidemiologic
data were used to initiate the standard-setting
process. The pressures to regulate came largely
from unions, chiefly from the Oil, Chemical and
Atomic Workers and the Steelworkers unions. At
the public hearings involved in the regulatory
process to set a standard, a lot of epidemiologic
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evidence was brought forward that really should
have been used to initiate the proceedings in the
first place. Animal data were usually ignored.
They just do not get considered in the way they
should be. From his experience with the standard
setting process, science does not play a great part
in where the standard is set. For example, in the
cases of kepone, DVCP or asbestos, he did not
think epidemiologic data were really the relevant
issue. The conflicting pressures between the unions,
on one side, wanting standards set, and industry,
on the other side, wanting the standard to be
feasible from an economic point of view, were the
major determinants in setting standards for those
substances.
Dr. Martin Hines (Division of Health Services,
State of North Carolina) said that the cotton dust
standard of OSHA was set almost exclusively on
the basis of epidemiologic studies done by the
State Health Department in North Carolina. He
had been discouraged by a great lack of concern
about occupational disease by organized unions
and labor. While his group had struggled to do this
epidemiologic study in the textile mills, he did not
get any encouragement from labor unions to help
with it. Unions may be very interested in the final
standard, but when the real work was being done
to define health risks they were not there. Dr.
Parkinson replied that if anyone tried to do any-
thing about occupational health in a nonunion
shop, people lose theirjobs. Therefore, you cannot
study or prevent occupational disease in an unor-
ganized workforce in North America because peo-
ple just get fired, and they disappear and are
never seen again.
Dr. Radford asked Dr. Kline, were the dose-
response curves that she showed fitted a priori, or
were they fitted to the data itself? He had noticed
she did not show any data points on her graphs
and he was concerned whether in fact one could
just as well have drawn any of the variety of
dose-response curves that we had heard about
earlier in this symposium. Dr. Kline replied they
were not fitted a priori. As far as the abortion
data go, the curves were fitted by using maximum
likelihood logistic regression. Before Kline et al.
had started thinking about dose-response curves
for this conference, they had analyzed the smoking
data in three categories: nonsmokers, women who
smoked up to 13 cigarettes, and women who
smoked from 14 to 80 cigarettes. From these data,
they suspected that the curve should be S-shaped,
and plateau after about 20 cigarettes. The curves
which were fit, fit very well; the value for the x2
between the observed and expected values was on
the order of0.50, but there are a number ofcurves
Environmental Health Perspectivesthat might have fit. The smoking data were not fit
well by a linear curve, which was the first curve
they attempted. The poor fit was owed not to
effects at the low doses, but to effects at high
doses where there was a definite plateau. There is
no question that women who were smoking 40
cigarettes a day did not show effects where a
linear curve would predict. A quadratic component
was added to the linear term and this component
was significant. However, they did not think such
a curve made biological sense because eventually it
would turn down and then smoking would become
protective. They turned then to the logarithmic
curve which fit the data at the full range of doses
studied. This function has the advantage that it
plateaus at the higher doses. A threshold model
also gave a good fit at low doses; indeed there was
not sufficient power to distinguish between a
threshold and logarithmic model at low doses (1-4
cigarettes).
Dr. Hunt stated that we have all watched with
interest development ofdata on the relationship of
smoking to the high risk of early abortion, yet
with normal chromosome complement. She asked
Dr. Kline whether the same situation holds for
alcohol. Dr. Kline replied that results for alcohol
are a bit more complicated. There is definitely an
association between alcohol and abortion of chro-
mosomally normal conceptions. When she spoke of
chromosomally normal fetuses in relation to smok-
ing, she was talking specifically about well-formed
fetuses. A lot ofabortions seen are empty sacs and
growth-disorganized embryos. These are instances
where development is stopped very early in gesta-
tion. Once you have a well-formed fetus, develop-
ment has progressed at least beyond 10 weeks.
With excess alcohol intake by the mother, associa-
tion is with abortion of chromosomally normal
conceptions of all sorts, but they also have found a
strange unexplained association with the abortion
of nontrisomic chromosomally abnormal concep-
tions. In the data last analyzed, the numbers were
really too small to distinguish the type of aneu-
ploidy which may be associated with alcohol drink-
ing. The numbers are probably just about big
enough to go back and see ifthey can replicate the
association of alcohol drinking with aneuploidy and
also to study which chromosomal anomalies, ifany,
are associated with drinking. Since nearly all
anomalies arise before or during conception, an
effect would have to be ascribed to drinking before
conception. There is, of course, overlap in women
who drink frequently prior to conception and
during pregnancy.
Dr. Hunt commented that perhaps the data base
now being developed with these methods can be
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used for evaluating the effect of exposure of
women to toxic substances-either during preg-
nancy or prior to conception-for example, inves-
tigation ofeffects offat-soluble organic compounds.
She asked Dr. Kline from her experience whether
we are at the stage where we can use these results
as preliminary data or whether there will be
limitations in using worker populations.
Dr. Kline responded that they have been think-
ing about this problem because, of course, it is
enormously difficult to collect a series ofabortions,
so that if one could take their series and those of
others and use these as comparison groups, a good
deal of time and money would be saved. As far as
the chromosomal anomalies go, their series of
abortions and some of the other series probably
provide useful comparison groups. Although they
have a good deal of information on independent
variables which may need control (e.g., smoking,
alcohol use), many series of karyotyped abortions
do not include this information, and thus there are
limitations to the use of these data. Of the five or
six series of karyotyped spontaneous abortions,
there are many similarities and also some interest-
ing dissimilarities. But there are more similarities
than dissimilarities and once one knows the gesta-
tional state of the pregnancy and the maternal
age, estimates of the frequency and type of anom-
aly across studies are similar, suggesting that
adjustment for these factors may be sufficient for
some comparisons.
Their data are probably not very useful for
prediction of rates of spontaneous abortion, partly
because of study design. Although they have set
out rates for spontaneous abortions using all abor-
tions and live births coming to the study hospitals,
they are not able to define precisely for these two
differentreproductive outcomesthe cohortofwomen
who use these hospitals. If one wanted to examine
whether the rate of abortion was raised in a
factory, for instance, it might be difficult to locate
an appropriate comparison group. In the literature
there are several series where abortion rates are
given for a cohort of pregnancies, and these may
sometimes provide a rather gross test of whether
the rate of abortion appears raised in a particular
setting.
Dr. Hunt asked whether data comparable inter-
nationally and across racial groups had been found.
Dr. Kline stated they had not yet found what they
thought was a racial difference in their studies.
Jacobs has a series in Hawaii which is even more
diverse with respect to race than their New York
population, and she does not find any racial varia-
tion. In New York there is an unexplained associa-
tion of socioeconomic status with triploidy in their
145series. Among the private patients, that is the
women of high socioeconomic level, there is an
excess of triploidy, a particular kind of chromo-
somal anomaly. Interestingly enough, this is one of
the anomalies which varies most between studies
across the world. The association seems to be with
social class rather than with race; however, it is
difficult to disentangle race and social class because
the private patients are nearly all white and public
patients are not.
Barbara Hays (University of Pittsburgh) spoke
as an environmentalist who had attended the
conference just to listen. Much of this symposium
on environmental epidemiology has dealt with the
problem of how you use epidemiology for standard
setting. She thought the conferees had lost sight of
the fact that people concerned with the environ-
mental quality are talking, for example, about
clean air or clean water. They are not worried
simply about whether materials in water or air are
going to give us cancer or an excess of miscar-
riages or something like that. As Dr. Radford had
said earlier, we should be aware ofthe perceptions
of people about their environment, and what they
perceive as a safe or pleasant environment. Some-
how we need to learn how to quantitate these
perceptions, because these really represent peo-
ple's goals. She had the feeling that the emphasis
on health is primarily because ofthe ways laws are
written. Perhaps that is because the only way to
achieve environmental quality is by moving en-
trenched economic interests to change the way
they do things, and this can only be done by
emphasis on health effects such as production of
cancer or miscarriages. But somehow we need to
be able to get at some of these perceptions of
people, that don't have such long-term endpoints,
like cancer. She hoped there would be some way of
quantifying the behavioral effects on people, such
as headaches or more frequent illnesses, and
relating those to environmental degradation.
Dr. Nurtan A. Esmen (University of Pitts-
burgh) was bothered by her comments because
perception of the environment is very subjective.
When W. C. Fields was living he objected to very
clean water; he liked his water contaminated with
alcohol. What one person perceives as clean and
what someone else perceives as clean may be
completely different. We have to try to define
what clean is. Somewhere one must make some
sort of tests, some epidemiological study of these
effects. The endpoint could be some index of
perception. Dr. Jeff Beaubier (EPA, Research
Triangle Park) commented that in parts of the
world where there is low per capita income but
still a high life expectancy, in such places perhaps
these qualities of the environment have contrib-
uted to longevity. For example, villages in Greece
or Sweden have very good qualities of environ-
ment, and possibly therefore higher life expectancy.
Dr. Hunt summed up by pointing out that we
have brought together at this symposium an inte-
gration of the imperfections of the real world and
attempts to reach perfection in epidemiologic stud-
ies. The fact is that we have a responsibility to get
as good answers as we can to the effects of the
environment on people, while well aware that we
have a wide range ofvariation in people to deal with.
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